Covidien (COV) Tops Q3 EPS by 4c

Covidien (NYSE: COV) reported Q3 EPS of $1.04, $0.04 better than the analyst estimate of $1.00. Revenue for the quarter came in at $2.69 billion versus the consensus estimate of $2.69 billion.

For earnings history and earnings-related data on Covidien (COV) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Cantor Fitzgerald Reiterates Overweight Rating on Global Net Lease (GNL)
• Azitra, Inc. (AZTR) Tops Q2 EPS by 54c